Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Babu Joseph

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Journal of Medicinal Chemistry|December 28, 2021
Correction to "Design, Synthesis, and Characterization of 4-Aminoquinazolines as Potent Inhibitors of the G Protein-Coupled Receptor Kinase 6 (GRK6) for the Treatment of Multiple Myeloma"David E Uehling, Babu Joseph, Kim Chan Chung, et al.
Journal of Medicinal Chemistry|July 22, 2021
Design, Synthesis, and Characterization of 4-Aminoquinazolines as Potent Inhibitors of the G Protein-Coupled Receptor Kinase 6 (GRK6) for the Treatment of Multiple MyelomaDavid E Uehling, Babu Joseph, Kim Chan Chung, et al.
Bioorganic & Medicinal Chemistry Letters|November 15, 2025
Structure-based discovery of sulfamoyl-ethyl-4-oxo-3,4-dihydro-7H-pyrrolo[2,3-d]pyrimidine amides and sulfonamides as potent B-Cell Lymphoma 6 (BCL6)-BTB inhibitorsAhmed Mamai, Mohammed M Morshed, Michael Prakesch, et al.
Nature Chemical Biology|February 26, 2020
A drug discovery platform to identify compounds that inhibit EGFR triple mutantsPunit Saraon, Jamie Snider, Yannis Kalaidzidis, et al.
Journal of Molecular Biology|October 18, 2021
Chemical Genetics Screen Identifies COPB2 Tool Compounds That Alters ER Stress Response and Induces RTK Dysregulation in Lung Cancer CellsPunit Saraon, Jamie Snider, Wiebke Schormann, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Journal of Medicinal Chemistry|December 28, 2021
Correction to "Design, Synthesis, and Characterization of 4-Aminoquinazolines as Potent Inhibitors of the G Protein-Coupled Receptor Kinase 6 (GRK6) for the Treatment of Multiple Myeloma"David E Uehling, Babu Joseph, Kim Chan Chung, et al.
Journal of Medicinal Chemistry|July 22, 2021
Design, Synthesis, and Characterization of 4-Aminoquinazolines as Potent Inhibitors of the G Protein-Coupled Receptor Kinase 6 (GRK6) for the Treatment of Multiple MyelomaDavid E Uehling, Babu Joseph, Kim Chan Chung, et al.
Bioorganic & Medicinal Chemistry Letters|November 15, 2025
Structure-based discovery of sulfamoyl-ethyl-4-oxo-3,4-dihydro-7H-pyrrolo[2,3-d]pyrimidine amides and sulfonamides as potent B-Cell Lymphoma 6 (BCL6)-BTB inhibitorsAhmed Mamai, Mohammed M Morshed, Michael Prakesch, et al.
Nature Chemical Biology|February 26, 2020
A drug discovery platform to identify compounds that inhibit EGFR triple mutantsPunit Saraon, Jamie Snider, Yannis Kalaidzidis, et al.
Journal of Molecular Biology|October 18, 2021
Chemical Genetics Screen Identifies COPB2 Tool Compounds That Alters ER Stress Response and Induces RTK Dysregulation in Lung Cancer CellsPunit Saraon, Jamie Snider, Wiebke Schormann, et al.
Pageof 5